Market Cap

Lonza Group Ltd Market Capitalization:

CHF25.60 Billion

CHF as of Jan. 1, 2024

US$30.42 Billion

business Lonza Group Ltd Company Profile

Lonza Group Ltd Main Stock Listing

SIX: LONN

Market Capitalization History of Lonza Group Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $207.62 B
Danaher $171.89 B
Siemens Healthineers AG $66.05 B
DexCom, Inc. $46.50 B
IDEXX Laboratories, Inc. $44.72 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Lonza Group Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 CHF25.60 B -26.18%
Jan. 1, 2023 CHF34.68 B -25.92%
Jan. 1, 2022 CHF46.82 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Lonza Group Ltd Categories

Switzerland languages Healthcare languages Diagnostics & Research
Switzerland Healthcare Switzerland Diagnostics & Research

Stocks & Indices

Lonza Group Ltd has the following listings and related stock indices.


Stock: SIX: LONN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.